6-K 1 a8207y.htm DIRECTOR/PDMR SHAREHOLDING a8207y
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
For the month of May 2023
 
Commission File Number 001-15170
 
 
GSK plc
(Translation of registrant's name into English)
 
 
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive office)
 
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
 
 
 
 
GSK plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Sir Jonathan Symonds
b)
Position/status
 
Non-Executive Chair
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
 
GSK plc
b)
LEI
 
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
 
b)
Nature of the transaction
Release of 35,439 notional Ordinary Shares from the GSK Non-Executive Director Share Allocation Arrangements prior to termination of those arrangements, the withholding of 16,656 notional Ordinary Shares for tax and the final release of 18,782 Ordinary Shares representing the balance. These shares will be held by Sir Jonathan Symonds until he retires from the Board
 
c)
Price(s) and volume(s)
 
Price(s)
 
Volume(s)
 
 
£14.556
 
18,782
 
 
 
 
 
d)
Aggregated information
 
N/A (single transaction)
Aggregated volume
Price
 
 
e)
Date of the transaction
 
2023-05-04
f)
Place of the transaction
 
London Stock Exchange (XLON)
 
 
1.
 
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
 
Mr Urs Rohner
b)
Position/status
 
Independent Non-Executive Director
c)
Initial notification/amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
 
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
 
b)
 
Nature of the transaction
 
Release of 19,083 notional Ordinary Shares from the GSK Non-Executive Director Share Allocation Arrangements prior to termination of those arrangements, the withholding of 4,446 notional Ordinary Shares for tax and the final release of 14,637 Ordinary Shares representing the balance. These shares will be held by Mr Rohner until he retires from the Board
 
c)
 
Price(s) and volume(s)
 
 
Price(s)
 
Volume(s)
 
 
 
£14.556
 
14,637
 
 
 
 
 
 
d)
 
Aggregated information
 
N/A (single transaction)
 
Aggregated volume
Price
 
 
e)
Date of the transaction
 
2023-05-04
f)
Place of the transaction
 
London Stock Exchange (XLON)
 
 
 
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
GSK plc
 
(Registrant)
 
 
Date: May 9, 2023
 
 
 
 
By:/s/ VICTORIA WHYTE
--------------------------
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GSK plc